太費時間了,找到這個供參考。在這裏規則是要遵守的,不然執照不保。

本文內容已被 [ 鍋沿 ] 在 2023-01-19 04:44:51 編輯過。如有問題,請報告版主或論壇管理刪除.

Once you’ve been ill with the virus for more than a week, the damage done to the body in a severe case can’t be undone by the antiviral,” he says.https://www.yalemedicine.org/news/13-things-to-know-paxlovid-covid-19

•    PAXLOVID is not authorized for initiation of treatment in patients requiring hospitalization due to severe or critical COVID-19.https://www.pfizer.com/news/press-release/press-release-detail/pfizer-receives-us-fda-emergency-use-authorization-novel

我沒有找到試驗數據,不等於沒有。為什麽不授權應用於重症?為什麽不能救人於危難之中?我想

藥商應該比我這個草民要清楚的多,授權一年多了,沒有想有突破?現在試驗用於長新冠( https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=Paxlovid&cntry=US&state=&city=&dist=

)……。我同意醫生們講的病毒載量的問題,它對應的病毒載量是一定程度的。

為什麽要5天內開始服用,這應該了解新冠的自然病程。

 

所有跟帖: 

請您先登陸,再發跟帖!